The estimated Net Worth of Valerie Barber Palmieri is at least $1.8 Million dollars as of 28 June 2019. Ms. Palmieri owns over 37,500 units of Vermillion stock worth over $862,252 and over the last 10 years she sold VRML stock worth over $0. In addition, she makes $941,832 as President, Chief Executive Officer und Director at Vermillion.
Sign up
Ms. Palmieri VRML stock SEC Form 4 insiders trading
Valerie has made over 11 trades of the Vermillion stock since 2014, according to the Form 4 filled with the SEC. Most recently she bought 37,500 units of VRML stock worth $30,000 on 28 June 2019.
The largest trade she's ever made was buying 97,000 units of Vermillion stock on 17 August 2018 worth over $50,440. On average, Valerie trades about 9,117 units every 76 days since 2014. As of 28 June 2019 she still owns at least 215,563 units of Vermillion stock.
You can see the complete history of Ms. Palmieri stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Valerie Palmieri biography
Valerie Barber Palmieri serves as President, Chief Executive Officer, Director of the Company., since January 1, 2015. was appointed as our President and Chief Executive Officer in January 2015 and was elected to our Board in June 2015. She first joined Vermillion as Chief Operating Officer in October 2014. Ms. Palmieri brings to Vermillion more than 30 years of experience in the diagnostic laboratory industry, serving in numerous sales, operations, and executive leadership positions for both laboratory service and consulting organizations. From April 2009 to October 2014, Ms. Palmieri was the President and Chief Executive Officer of Momentum Consulting, LLC, a national consulting firm serving the life science and diagnostic laboratory industries. During her time at Momentum, Ms. Palmieri also served as CEO/President of two healthcare start-ups that resulted in a successful exit for one and won her recognition as one of the “Top 10 Entrepreneurs of Springboard Enterprises” for the other. Prior to that she spent six years as the National Vice President of Anatomic Pathology Operations with LabCorp, one of the largest public diagnostic laboratories in the world. LabCorp was the successor company to Dianon Systems, also a publicly traded company, where she served as Senior Vice President of Operations. She was a key leader in the sale of Dianon to LabCorp in 2003. Ms. Palmieri holds a Bachelor of Science degree in Medical Technology from Western Connecticut State University.
What is the salary of Valerie Palmieri?
As the President, Chief Executive Officer und Director of Vermillion, the total compensation of Valerie Palmieri at Vermillion is $941,832. There are no executives at Vermillion getting paid more.
How old is Valerie Palmieri?
Valerie Palmieri is 58, she's been the President, Chief Executive Officer und Director of Vermillion since 2015. There are 4 older and 1 younger executives at Vermillion. The oldest executive at Vermillion, Inc. is James Burns, 73, who is the Independent Director.
What's Valerie Palmieri's mailing address?
Valerie's mailing address filed with the SEC is C/O VERMILLION, INC., 12117 BEE CAVES RD, BLDG 3 STE 100, AUSTIN, TX, 78738.
Insiders trading at Vermillion
Over the last 17 years, insiders at Vermillion have traded over $1,008,376 worth of Vermillion stock and bought 29,557,130 units worth $34,088,488 . The most active insiders traders include Jack W Schuler, Henri George Schuler und Larry Noracle Partners Lp F.... On average, Vermillion executives and independent directors trade stock every 59 days with the average trade being worth of $1,572,028. The most recent stock trade was executed by Robert Harry Beechey on 15 November 2019, trading 5,000 units of VRML stock currently worth $3,550.
What does Vermillion do?
Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
What does Vermillion's logo look like?
Complete history of Ms. Palmieri stock trades at Vermillion
Vermillion executives and stock owners
Vermillion executives and other stock owners filed with the SEC include:
-
Valerie Palmieri,
President, Chief Executive Officer, Director -
Robert Beechey,
Chief Financial Officer -
Nancy Cocozza,
Independent Director -
James LaFrance,
Independent Chairman of the Board -
Veronica Jordan,
Independent Director -
David Schreiber,
Independent Director -
James Burns,
Independent Director -
Sandra Brooks,
Independent Director -
Jack W Schuler,
-
Peter S Roddy,
Director -
Carl Severinghaus,
Director -
Larry Noracle Partners Lp O...,
-
Donald G Munroe,
SVP Business Development & CSO -
Henri George Schuler,
10% owner -
Holly B Bauzon,
VP Managed Markets -
Fred Ferrara,
Chief Information Officer -
Rajen Dalal,
Director -
Gail S Page,
President and CEO -
Qun Zhou,
Interim CFO -
Laura Ann Miller,
SVP Sales & Cust Experience -
Robert St Leger Goggin,
Director -
Ashish Kohli,
VP of Corporate Strategy -
Michael J Callaghan,
Director -
Marian E Sacco,
See Remarks -
Thomas H Mclain,
CEO & President -
James L Rathmann,
Director -
Eric Varma,
Director -
Larry Noracle Partners Lp O...,
-
John F Hamilton,
Director -
William C Wallen,
Director -
Bruce A Huebner,
Director -
William B. Creech,
VP Sales and Marketing -
Eric Schoen,
VP Finance & CAO -
Eric T Fung,
VP-Chief Science Officer -
Sandra A. Gardiner,
VP & Chief Financial Officer -
Judy Bruner,
Director -
Partners L Pwiggins James P...,
-
Diagnostics Inc Quest,
10% owner -
Kenneth J Conway,
Director -
Simon C. Shorter,
VP, Corp Business Development -
John A Young,
Director -
Larry Noracle Partners Lp F...,